Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
AMRX holding history
Amneal Pharmaceuticals, Inc. in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −23,100−100.0% | Sold out | Holders |
| Q2 2023 | 23,100 | $71.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 23,100 | $32.1K | <0.1% | +23,100 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −146,500−100.0% | Sold out | Holders |
| Q2 2022 | 146,500 | $466.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 146,500 | $611.0K | <0.1% | +122,100+500.4% | Added | Holders |
| Q4 2021 | 24,400 | $117.0K | <0.1% | +24,400 | New | Holders |